tirzepatide to semaglutide dose conversion Switching semaglutide to tirzepatide dose conversion

doi: 10.1039/C6MD00358C

Weight loss was a well known side effect, which is partly what led to newer versions being licensed specifically for weight management

Other Potential Issues: There may be certain medical conditions or histories, such as personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) where this type of drug is not recommended

Obstructive sleep apnea, highly prevalent in obesity, contributes to ED through intermittent hypoxia, sympathetic activation, and disrupted sleep architecture

For more information on GLP-1 therapies, see the European Medicines Agencys overview of Ozempic